Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q64183498
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000234.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q64183498
|
024
|
|
|
‡a
0000-0002-8819-2443
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q64183498
|
100
|
0 |
|
‡a
Chun Li
‡c
researcher ORCID 0000-0002-8819-2443
‡9
en
|
400
|
0 |
|
‡a
Chun Li
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14
|
670
|
|
|
‡a
Author's A new residual for ordinal outcomes
|
670
|
|
|
‡a
Author's A novel, noninvasive assay shows that distal airway oxygen tension is low in cystic fibrosis, but not in primary ciliary dyskinesia
|
670
|
|
|
‡a
Author's A powerful association test of multiple genetic variants using a random-effects model.
|
670
|
|
|
‡a
Author's A prevalence-based association test for case-control studies.
|
670
|
|
|
‡a
Author's A statistical reappraisal of the findings of an esophageal cancer genome-wide association study
|
670
|
|
|
‡a
Author's A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study
|
670
|
|
|
‡a
Author's Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction
|
670
|
|
|
‡a
Author's Association of genetic variation with blood pressure traits among East Africans.
|
670
|
|
|
‡a
Author's Associations of plasma-soluble fas ligand with aging and age-related macular degeneration
|
670
|
|
|
‡a
Author's Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.
|
670
|
|
|
‡a
Author's Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.
|
670
|
|
|
‡a
Author's Covariate-adjusted Spearman's rank correlation with probability-scale residuals.
|
670
|
|
|
‡a
Author's Design of DNA pooling to allow incorporation of covariates in rare variants analysis
|
670
|
|
|
‡a
Author's Detecting gene-gene interaction in linkage analysis.
|
670
|
|
|
‡a
Author's Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.
|
670
|
|
|
‡a
Author's Effects of environment, genetics and data analysis pitfalls in an esophageal cancer genome-wide association study.
|
670
|
|
|
‡a
Author's Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.
|
670
|
|
|
‡a
Author's Enriching targeted sequencing experiments for rare disease alleles.
|
670
|
|
|
‡a
Author's Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.
|
670
|
|
|
‡a
Author's First-time failure rates of candidates for board certification: an educational outcome measure
|
670
|
|
|
‡a
Author's Genetic association analysis using data from triads and unrelated subjects
|
670
|
|
|
‡a
Author's Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
|
670
|
|
|
‡a
Author's Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus
|
670
|
|
|
‡a
Author's Genetic variation in the Alpha 1B-adrenergic receptor and vascular response.
|
670
|
|
|
‡a
Author's Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans
|
670
|
|
|
‡a
Author's Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.
|
670
|
|
|
‡a
Author's Genetic variation near the hepatocyte nuclear factor-4 Alpha gene predicts susceptibility to type 2 diabetes
|
670
|
|
|
‡a
Author's Genetic variations in the α
|
670
|
|
|
‡a
Author's Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine
|
670
|
|
|
‡a
Author's Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis
|
670
|
|
|
‡a
Author's Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202
|
670
|
|
|
‡a
Author's Genotype and risk of major bleeding during warfarin treatment
|
670
|
|
|
‡a
Author's GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
|
670
|
|
|
‡a
Author's Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
|
670
|
|
|
‡a
Author's Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium
|
670
|
|
|
‡a
Author's Identification of new genetic risk variants for type 2 diabetes
|
670
|
|
|
‡a
Author's Joint analyses of multi-tissue Hi-C and eQTL data demonstrate close spatial proximity between eQTLs and their target genes
|
670
|
|
|
‡a
Author's Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk
|
670
|
|
|
‡a
Author's Longitudinal follow-up of hypermetropic children identified during preschool vision screening.
|
670
|
|
|
‡a
Author's Meta-analysis identifies common variants associated with body mass index in east Asians
|
670
|
|
|
‡a
Author's Modeling continuous response variables using ordinal regression
|
670
|
|
|
‡a
Author's Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure.
|
670
|
|
|
‡a
Author's Optimized selection of unrelated subjects for whole-genome sequencing studies of rare high-penetrance alleles.
|
670
|
|
|
‡a
Author's Probability-scale residuals for continuous, discrete, and censored data
|
670
|
|
|
‡a
Author's Racial disparity in amniotic fluid concentrations of tumor necrosis factor
|
670
|
|
|
‡a
Author's Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)- Alpha and soluble TNF receptors in spontaneous preterm birth.
|
670
|
|
|
‡a
Author's Soft Tissue Metrics in Thyroid Eye Disease: An International Thyroid Eye Disease Society Reliability Study.
|
670
|
|
|
‡a
Author's Strategy for encoding and comparison of gene expression signatures.
|
670
|
|
|
‡a
Author's Test of Association Between Two Ordinal Variables While Adjusting for Covariates
|
670
|
|
|
‡a
Author's Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells
|
670
|
|
|
‡a
Author's The age-dependent effect of anisometropia magnitude on anisometropic amblyopia severity
|
670
|
|
|
‡a
Author's The failure rate of candidates for board certification: an educational outcome measure.
|
670
|
|
|
‡a
Author's The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics
|
670
|
|
|
‡a
Author's The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci.
|
670
|
|
|
‡a
Author's Underestimation of soft tissue entrapment by computed tomography in orbital floor fractures in the pediatric population.
|
670
|
|
|
‡a
Author's Use of cox-2 inhibitors in patients with retinal venous occlusive disease.
|
670
|
|
|
‡a
Author's Variations in the Alpha 2A-adrenergic receptor gene and their functional effects.
|
909
|
|
|
‡a
(orcid) 0000000288192443
‡9
1
|
912
|
|
|
‡a
heightandbreastcancerriskevidencefromprospectivestudiesandmendelianrandomization
‡A
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
‡9
1
|
919
|
|
|
‡a
strategyforencodingandcomparisonofgeneexpressionsignatures
‡A
Strategy for encoding and comparison of gene expression signatures.
‡9
1
|
919
|
|
|
‡a
testofassociationbetween2ordinalvariableswhileadjustingforcovariates
‡A
Test of Association Between Two Ordinal Variables While Adjusting for Covariates
‡9
1
|
919
|
|
|
‡a
tgif1regulatesquiescenceandselfrenewalofhematopoieticstemcells
‡A
Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells
‡9
1
|
919
|
|
|
‡a
agedependenteffectofanisometropiamagnitudeonanisometropicamblyopiaseverity
‡A
The age-dependent effect of anisometropia magnitude on anisometropic amblyopia severity
‡9
1
|
919
|
|
|
‡a
failurerateofcandidatesforboardcertificationaneducationaloutcomemeasure
‡A
The failure rate of candidates for board certification: an educational outcome measure.
‡9
1
|
919
|
|
|
‡a
variationsinthe Alpha 2aadrenergicreceptorgeneandtheirfunctionaleffects
‡A
Variations in the Alpha 2A-adrenergic receptor gene and their functional effects.
‡9
1
|
919
|
|
|
‡a
finlandunitedstatesinvestigationofnoninsulindependentdiabetesmellitusgenetics
‡A
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics
‡9
1
|
919
|
|
|
‡a
effectofthevkorc1d36yvariantonwarfarindoserequirementandpharmacogeneticdoseprediction
‡A
Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.
‡9
1
|
919
|
|
|
‡a
efficacyofabirateroneandenzalutamideinpreandpostdocetaxelcastrationresistantprostatecanceratriallevelmetaanalysis
‡A
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.
‡9
1
|
919
|
|
|
‡a
enrichingtargetedsequencingexperimentsforrarediseasealleles
‡A
Enriching targeted sequencing experiments for rare disease alleles.
‡9
1
|
919
|
|
|
‡a
estrogenexposuremetabolismandenzymevariantsinamodelforbreastcancerriskprediction
‡A
Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.
‡9
1
|
919
|
|
|
‡a
1timefailureratesofcandidatesforboardcertificationaneducationaloutcomemeasure
‡A
First-time failure rates of candidates for board certification: an educational outcome measure
‡9
1
|
919
|
|
|
‡a
newresidualforordinaloutcomes
‡A
A new residual for ordinal outcomes
‡9
1
|
919
|
|
|
‡a
novelnoninvasiveassayshowsthatdistalairwayoxygentensionislowincysticfibrosisbutnotinprimaryciliarydyskinesia
‡A
A novel, noninvasive assay shows that distal airway oxygen tension is low in cystic fibrosis, but not in primary ciliary dyskinesia
‡9
1
|
919
|
|
|
‡a
finlandunitedstatesinvestigationofnoninsulindependentdiabetesmellitusgeneticsfusionstudy2anautosomalgenomescanfordiabetesrelatedquantitativetraitloci
‡A
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci.
‡9
1
|
919
|
|
|
‡a
underestimationofsofttissueentrapmentbycomputedtomographyinorbitalfloorfracturesinthepediatricpopulation
‡A
Underestimation of soft tissue entrapment by computed tomography in orbital floor fractures in the pediatric population.
‡9
1
|
919
|
|
|
‡a
useofcox2inhibitorsinpatientswithretinalvenousocclusivedisease
‡A
Use of cox-2 inhibitors in patients with retinal venous occlusive disease.
‡9
1
|
919
|
|
|
‡a
geneticassociationanalysisusingdatafromtriadsandunrelatedsubjects
‡A
Genetic association analysis using data from triads and unrelated subjects
‡9
1
|
919
|
|
|
‡a
geneticpolymorphismsintheigfbp3geneassociationwithbreastcancerriskandbloodigfbp3proteinlevelsamongchinesewomen
‡A
Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
‡9
1
|
919
|
|
|
‡a
geneticvariationandcoronaryatherosclerosisinpatientswithsystemiclupuserythematosus
‡A
Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus
‡9
1
|
919
|
|
|
‡a
powerfulassociationtestofmultiplegeneticvariantsusingarandomeffectsmodel
‡A
A powerful association test of multiple genetic variants using a random-effects model.
‡9
1
|
919
|
|
|
‡a
geneticvariationinthe Alpha 1badrenergicreceptorandvascularresponse
‡A
Genetic variation in the Alpha 1B-adrenergic receptor and vascular response.
‡9
1
|
919
|
|
|
‡a
geneticvariationinthepresynapticnorepinephrinetransporterisassociatedwithbloodpressureresponsestoexerciseinhealthyhumans
‡A
Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans
‡9
1
|
919
|
|
|
‡a
prevalencebasedassociationtestforcasecontrolstudies
‡A
A prevalence-based association test for case-control studies.
‡9
1
|
919
|
|
|
‡a
geneticvariationintheα1aadrenergicreceptorandphenylephrinemediatedvenoconstriction
‡A
Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.
‡9
1
|
919
|
|
|
‡a
statisticalreappraisalofthefindingsofanesophagealcancergenomewideassociationstudy
‡A
A statistical reappraisal of the findings of an esophageal cancer genome-wide association study
‡9
1
|
919
|
|
|
‡a
geneticvariationnearthehepatocytenuclearfactor4 Alpha genepredictssusceptibilitytotype2diabetes
‡A
Genetic variation near the hepatocyte nuclear factor-4 Alpha gene predicts susceptibility to type 2 diabetes
‡9
1
|
919
|
|
|
‡a
geneticvariationsintheα
‡A
Genetic variations in the α
‡9
1
|
919
|
|
|
‡a
geneticvariationsintheα2aadrenoreceptorareassociatedwithbloodpressureresponsetotheagonistdexmedetomidine
‡A
Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine
‡9
1
|
919
|
|
|
‡a
geneticsofserumconcentrationofil6andtnfαinsystemiclupuserythematosusandrheumatoidarthritisacandidategeneanalysis
‡A
Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis
‡9
1
|
919
|
|
|
‡a
genomewideassociationstudyoftenofovirpharmacokineticsandcreatinineclearanceinaidsclinicaltrialsgroupprotocol
‡A
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202
‡9
1
|
919
|
|
|
‡a
genotypeandriskofmajorbleedingduringwarfarintreatment
‡A
Genotype and risk of major bleeding during warfarin treatment
‡9
1
|
919
|
|
|
‡a
grk5gln41leupolymorphismisnotassociatedwithsensitivitytobeta1adrenergicblockadeinhumans
‡A
GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
‡9
1
|
919
|
|
|
‡a
identificationofafunctionalgeneticvariantat16q121forbreastcancerriskresultsfromtheasiabreastcancerconsortium
‡A
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium
‡9
1
|
919
|
|
|
‡a
identificationofnewgeneticriskvariantsfortype2diabetes
‡A
Identification of new genetic risk variants for type 2 diabetes
‡9
1
|
919
|
|
|
‡a
jointanalysesofmultitissuehi100andeqtldatademonstrateclosespatialproximitybetweeneqtlsandtheirtargetgenes
‡A
Joint analyses of multi-tissue Hi-C and eQTL data demonstrate close spatial proximity between eQTLs and their target genes
‡9
1
|
919
|
|
|
‡a
largescalegeneticstudyineastasiansidentifies6newlociassociatedwithcolorectalcancerrisk
‡A
Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk
‡9
1
|
919
|
|
|
‡a
longitudinalfollowupofhypermetropicchildrenidentifiedduringpreschoolvisionscreening
‡A
Longitudinal follow-up of hypermetropic children identified during preschool vision screening.
‡9
1
|
919
|
|
|
‡a
metaanalysisidentifiescommonvariantsassociatedwithbodymassindexineastasians
‡A
Meta-analysis identifies common variants associated with body mass index in east Asians
‡9
1
|
919
|
|
|
‡a
modelingcontinuousresponsevariablesusingordinalregression
‡A
Modeling continuous response variables using ordinal regression
‡9
1
|
919
|
|
|
‡a
morphometricchangesintheratopticnervefollowingshorttermintermittentelevationsinintraocularpressure
‡A
Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure.
‡9
1
|
919
|
|
|
‡a
optimizedselectionofunrelatedsubjectsforwholegenomesequencingstudiesofrarehighpenetrancealleles
‡A
Optimized selection of unrelated subjects for whole-genome sequencing studies of rare high-penetrance alleles.
‡9
1
|
919
|
|
|
‡a
probabilityscaleresidualsforcontinuousdiscreteandcensoreddata
‡A
Probability-scale residuals for continuous, discrete, and censored data
‡9
1
|
919
|
|
|
‡a
racialdisparityinamnioticfluidconcentrationsoftumornecrosisfactor
‡A
Racial disparity in amniotic fluid concentrations of tumor necrosis factor
‡9
1
|
919
|
|
|
‡a
racialdisparityinamnioticfluidconcentrationsoftumornecrosisfactortnf Alpha andsolubletnfreceptorsinspontaneouspretermbirth
‡A
Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)- Alpha and soluble TNF receptors in spontaneous preterm birth.
‡9
1
|
919
|
|
|
‡a
variantintheosteoprotegeringeneisassociatedwithcoronaryatherosclerosisinpatientswithrheumatoidarthritisresultsfromacandidategenestudy
‡A
A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study
‡9
1
|
919
|
|
|
‡a
Alpha 2aadrenergicreceptorgeneticvariationcontributestohyperglycemiaaftermyocardialinfarction
‡A
Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction
‡9
1
|
919
|
|
|
‡a
associationofgeneticvariationwithbloodpressuretraitsamongeastafricans
‡A
Association of genetic variation with blood pressure traits among East Africans.
‡9
1
|
919
|
|
|
‡a
associationsofplasmasolublefasligandwithagingandagerelatedmaculardegeneration
‡A
Associations of plasma-soluble fas ligand with aging and age-related macular degeneration
‡9
1
|
919
|
|
|
‡a
beta1adrenoceptorgeneticvariantsandethnicityindependentlyaffectresponsetobetablockade
‡A
Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.
‡9
1
|
919
|
|
|
‡a
catecholaminepathwaygenevariationisassociatedwithnorepinephrineandepinephrineconcentrationsatrestandafterexercise
‡A
Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.
‡9
1
|
919
|
|
|
‡a
largesetoffinnishaffectedsiblingpairfamilieswithtype2diabetessuggestssusceptibilitylocionchromosomes611and14
‡A
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14
‡9
1
|
919
|
|
|
‡a
covariateadjustedspearmansrankcorrelationwithprobabilityscaleresiduals
‡A
Covariate-adjusted Spearman's rank correlation with probability-scale residuals.
‡9
1
|
919
|
|
|
‡a
designofdnapoolingtoallowincorporationofcovariatesinrarevariantsanalysis
‡A
Design of DNA pooling to allow incorporation of covariates in rare variants analysis
‡9
1
|
919
|
|
|
‡a
detectinggenegeneinteractioninlinkageanalysis
‡A
Detecting gene-gene interaction in linkage analysis.
‡9
1
|
919
|
|
|
‡a
softtissuemetricsinthyroideyediseaseaninternationalthyroideyediseasesocietyreliabilitystudy
‡A
Soft Tissue Metrics in Thyroid Eye Disease: An International Thyroid Eye Disease Society Reliability Study.
‡9
1
|
919
|
|
|
‡a
effectsofenvironmentgeneticsanddataanalysispitfallsinanesophagealcancergenomewideassociationstudy
‡A
Effects of environment, genetics and data analysis pitfalls in an esophageal cancer genome-wide association study.
‡9
1
|
996
|
|
|
‡2
CAOONL|ncf11038952
|
996
|
|
|
‡2
ISNI|000000005693468X
|
996
|
|
|
‡2
DNB|142150827
|
996
|
|
|
‡2
ISNI|0000000063347360
|
996
|
|
|
‡2
ISNI|000000006372295X
|
996
|
|
|
‡2
LC|n 88102501
|
996
|
|
|
‡2
CAOONL|ncf11871897
|
996
|
|
|
‡2
LC|no2023016954
|
996
|
|
|
‡2
CYT|AC000000142
|
996
|
|
|
‡2
SUDOC|178991058
|
996
|
|
|
‡2
ISNI|0000000500454202
|
996
|
|
|
‡2
ISNI|0000000513355000
|
996
|
|
|
‡2
LC|no2020034896
|
996
|
|
|
‡2
CYT|AC000000898
|
996
|
|
|
‡2
DNB|1184590966
|
996
|
|
|
‡2
LC|no2004058853
|
996
|
|
|
‡2
ISNI|0000000433132472
|
996
|
|
|
‡2
LC|n 2023064170
|
996
|
|
|
‡2
CAOONL|ncf11511564
|
996
|
|
|
‡2
ISNI|0000000444641045
|
996
|
|
|
‡2
ISNI|0000000041071439
|
996
|
|
|
‡2
LC|no2017023540
|
996
|
|
|
‡2
BNF|17099413
|
996
|
|
|
‡2
NTA|407638822
|
996
|
|
|
‡2
BNE|XX5232463
|
996
|
|
|
‡2
LC|n 2019180526
|
996
|
|
|
‡2
ISNI|0000000064341315
|
996
|
|
|
‡2
CYT|AC000215206
|
996
|
|
|
‡2
CYT|AC000540636
|
996
|
|
|
‡2
LC|n 84149543
|
996
|
|
|
‡2
SUDOC|254790720
|
996
|
|
|
‡2
NUKAT|n 2018131000
|
996
|
|
|
‡2
LC|nr2005006104
|
996
|
|
|
‡2
DNB|1170637868
|
996
|
|
|
‡2
BNF|15582164
|
996
|
|
|
‡2
DNB|172225159
|
996
|
|
|
‡2
ISNI|0000000055562079
|
996
|
|
|
‡2
CYT|AC000008340
|
996
|
|
|
‡2
DNB|1261098757
|
996
|
|
|
‡2
DNB|1327371863
|
996
|
|
|
‡2
DNB|1137026189
|
996
|
|
|
‡2
ISNI|0000000063774282
|
996
|
|
|
‡2
ISNI|0000000054537314
|
996
|
|
|
‡2
CYT|AC000663460
|
996
|
|
|
‡2
J9U|987007298681605171
|
996
|
|
|
‡2
DNB|1207843059
|
996
|
|
|
‡2
ISNI|0000000375950951
|
996
|
|
|
‡2
NKC|utb2014821959
|
996
|
|
|
‡2
DNB|1113305053
|
996
|
|
|
‡2
LC|n 83066366
|
996
|
|
|
‡2
DNB|122116032X
|
996
|
|
|
‡2
LC|n 86117666
|
996
|
|
|
‡2
ISNI|0000000064085438
|
996
|
|
|
‡2
NTA|214147169
|
996
|
|
|
‡2
RERO|A028456038
|
996
|
|
|
‡2
CAOONL|ncf11864653
|
996
|
|
|
‡2
ISNI|0000000067010183
|
996
|
|
|
‡2
ISNI|0000000063512231
|
996
|
|
|
‡2
LC|no2014075540
|
996
|
|
|
‡2
PLWABN|9811288166005606
|
996
|
|
|
‡2
LC|nb2008006979
|
996
|
|
|
‡2
NTA|426165594
|
996
|
|
|
‡2
J9U|987007441117505171
|
996
|
|
|
‡2
CYT|AC000639587
|
996
|
|
|
‡2
LC|nr 98014760
|
996
|
|
|
‡2
LC|n 2019009795
|
996
|
|
|
‡2
CAOONL|ncf10227967
|
996
|
|
|
‡2
LC|no2006044069
|
996
|
|
|
‡2
ISNI|0000000082322679
|
996
|
|
|
‡2
ISNI|0000000078522934
|
996
|
|
|
‡2
DNB|110185507X
|
996
|
|
|
‡2
LC|n 80040082
|
996
|
|
|
‡2
ISNI|0000000067028770
|
996
|
|
|
‡2
KRNLK|KAC200208457
|
996
|
|
|
‡2
LC|n 2013182432
|
996
|
|
|
‡2
J9U|987007342503705171
|
996
|
|
|
‡2
CYT|AC000643309
|
996
|
|
|
‡2
BNF|17002044
|
996
|
|
|
‡2
DNB|1246722658
|
996
|
|
|
‡2
LC|nr2006014759
|
996
|
|
|
‡2
ISNI|0000000077421605
|
996
|
|
|
‡2
SUDOC|159901049
|
996
|
|
|
‡2
LC|n 85141474
|
996
|
|
|
‡2
ISNI|0000000063151894
|
996
|
|
|
‡2
SUDOC|273579819
|
996
|
|
|
‡2
LC|nr 93043688
|
996
|
|
|
‡2
CYT|AC000593958
|
996
|
|
|
‡2
LC|n 2015051780
|
996
|
|
|
‡2
ISNI|0000000094401737
|
996
|
|
|
‡2
DNB|1305564928
|
996
|
|
|
‡2
J9U|987010649704905171
|
996
|
|
|
‡2
ISNI|0000000424648354
|
996
|
|
|
‡2
ISNI|0000000070036499
|
996
|
|
|
‡2
ISNI|0000000426618327
|
996
|
|
|
‡2
DNB|1159024340
|
996
|
|
|
‡2
NYNYRILM|121369
|
996
|
|
|
‡2
LC|nr 91018952
|
996
|
|
|
‡2
ISNI|0000000032777149
|
996
|
|
|
‡2
DNB|1236576608
|
996
|
|
|
‡2
CAOONL|ncf11482258
|
996
|
|
|
‡2
CYT|AC000649720
|
996
|
|
|
‡2
SUDOC|258658177
|
996
|
|
|
‡2
LC|n 81078515
|
996
|
|
|
‡2
DNB|1207793272
|
996
|
|
|
‡2
LC|n 88276317
|
996
|
|
|
‡2
BNF|14406379
|
996
|
|
|
‡2
NII|DA06497240
|
996
|
|
|
‡2
DNB|1078456798
|
996
|
|
|
‡2
SUDOC|266369790
|
996
|
|
|
‡2
LC|nr 94042545
|
996
|
|
|
‡2
DNB|1275150055
|
996
|
|
|
‡2
BIBSYS|4085209
|
996
|
|
|
‡2
LC|n 83046311
|
996
|
|
|
‡2
BIBSYS|1100159
|
996
|
|
|
‡2
DNB|1110200897
|
996
|
|
|
‡2
LC|n 99017184
|
996
|
|
|
‡2
CYT|AC000216395
|
996
|
|
|
‡2
ISNI|0000000064208119
|
996
|
|
|
‡2
CYT|AC000216617
|
996
|
|
|
‡2
CYT|AC000216614
|
996
|
|
|
‡2
NTA|159040612
|
996
|
|
|
‡2
LC|n 2017030141
|
996
|
|
|
‡2
LC|nr 99019239
|
996
|
|
|
‡2
NII|DA1251774X
|
996
|
|
|
‡2
CAOONL|ncf11870097
|
996
|
|
|
‡2
PLWABN|9812199044905606
|
996
|
|
|
‡2
ISNI|0000000117052251
|
996
|
|
|
‡2
LC|no 00083233
|
996
|
|
|
‡2
BNF|17787501
|
996
|
|
|
‡2
LC|n 82085269
|
996
|
|
|
‡2
CAOONL|ncf11348098
|
996
|
|
|
‡2
BNF|16753029
|
996
|
|
|
‡2
ISNI|000000007287420X
|
996
|
|
|
‡2
J9U|987007388364505171
|
996
|
|
|
‡2
SUDOC|162033494
|
996
|
|
|
‡2
NII|DA11864522
|
996
|
|
|
‡2
NUKAT|n 2014052769
|
996
|
|
|
‡2
LC|no2003033064
|
996
|
|
|
‡2
LC|n 2018001814
|
996
|
|
|
‡2
NUKAT|n 2021008954
|
996
|
|
|
‡2
LC|nr2003023722
|
996
|
|
|
‡2
DNB|173606989
|
996
|
|
|
‡2
CYT|AC000215932
|
996
|
|
|
‡2
LC|n 2006096021
|
996
|
|
|
‡2
CYT|AC000215931
|
996
|
|
|
‡2
CYT|AC000215934
|
996
|
|
|
‡2
BIBSYS|1665604352592
|
996
|
|
|
‡2
PLWABN|9811562062405606
|
996
|
|
|
‡2
LC|nb2017025991
|
996
|
|
|
‡2
BNF|17073327
|
996
|
|
|
‡2
LC|nr 96026234
|
996
|
|
|
‡2
ISNI|0000000064208012
|
996
|
|
|
‡2
DNB|1268645273
|
996
|
|
|
‡2
NII|DA11466745
|
996
|
|
|
‡2
BNF|17782476
|
996
|
|
|
‡2
DNB|1051016339
|
996
|
|
|
‡2
DNB|1067832386
|
996
|
|
|
‡2
ISNI|0000000045770317
|
996
|
|
|
‡2
LC|nr 97005366
|
996
|
|
|
‡2
NII|DA11659771
|
996
|
|
|
‡2
SUDOC|234769742
|
996
|
|
|
‡2
ISNI|0000000037737349
|
996
|
|
|
‡2
ISNI|0000000367196362
|
996
|
|
|
‡2
DNB|1016394632
|
996
|
|
|
‡2
CYT|AC000216875
|
996
|
|
|
‡2
DNB|1315156172
|
996
|
|
|
‡2
CYT|AC000418158
|
996
|
|
|
‡2
DNB|1227483570
|
996
|
|
|
‡2
LC|n 2018007848
|
996
|
|
|
‡2
DNB|135702828
|
996
|
|
|
‡2
CYT|AC000632559
|
996
|
|
|
‡2
BNF|17014662
|
996
|
|
|
‡2
ISNI|0000000063614756
|
996
|
|
|
‡2
CYT|AC000495556
|
996
|
|
|
‡2
LNB|LNC10-000258680
|
996
|
|
|
‡2
SUDOC|03396145X
|
996
|
|
|
‡2
SUDOC|122151372
|
996
|
|
|
‡2
ISNI|0000000064248436
|
996
|
|
|
‡2
BNF|15108025
|
996
|
|
|
‡2
BIBSYS|1632996806229
|
996
|
|
|
‡2
LC|n 2016023097
|
996
|
|
|
‡2
DNB|131063937X
|
996
|
|
|
‡2
BIBSYS|90738495
|
996
|
|
|
‡2
LC|no2019068892
|
996
|
|
|
‡2
ISNI|0000000381698094
|
996
|
|
|
‡2
NUKAT|n 2012240690
|
996
|
|
|
‡2
CYT|AC000475627
|
996
|
|
|
‡2
ISNI|0000000083312501
|
996
|
|
|
‡2
LC|no2008107022
|
996
|
|
|
‡2
LC|no2004062396
|
996
|
|
|
‡2
NTA|323265480
|
996
|
|
|
‡2
LC|n 88194944
|
996
|
|
|
‡2
NII|DA07806329
|
996
|
|
|
‡2
ISNI|0000000063269710
|
996
|
|
|
‡2
CYT|AC000591572
|
996
|
|
|
‡2
LC|nr 96028617
|
996
|
|
|
‡2
CYT|AC000552631
|
996
|
|
|
‡2
SUDOC|116005297
|
996
|
|
|
‡2
DNB|128264064X
|
996
|
|
|
‡2
LC|n 90643389
|
996
|
|
|
‡2
ISNI|0000000064219088
|
996
|
|
|
‡2
LC|n 2005063562
|
996
|
|
|
‡2
NTA|207215286
|
996
|
|
|
‡2
NTA|364154128
|
996
|
|
|
‡2
DNB|1089651414
|
996
|
|
|
‡2
ISNI|0000000063778363
|
996
|
|
|
‡2
CYT|AC000590194
|
996
|
|
|
‡2
SUDOC|231560982
|
996
|
|
|
‡2
CYT|AC000643250
|
996
|
|
|
‡2
NII|DA10337816
|
996
|
|
|
‡2
ISNI|0000000458776549
|
996
|
|
|
‡2
ISNI|0000000076750642
|
996
|
|
|
‡2
J9U|987007345960405171
|
996
|
|
|
‡2
DNB|1171334788
|
996
|
|
|
‡2
LC|no 97059411
|
996
|
|
|
‡2
SUDOC|117561886
|
996
|
|
|
‡2
ISNI|0000000043567809
|
996
|
|
|
‡2
ISNI|0000000051709221
|
996
|
|
|
‡2
PLWABN|9814258275005606
|
996
|
|
|
‡2
DNB|1157497802
|
996
|
|
|
‡2
NTA|382731549
|
996
|
|
|
‡2
LC|no2018144101
|
996
|
|
|
‡2
PLWABN|9813224594305606
|
996
|
|
|
‡2
ISNI|0000000074185846
|
996
|
|
|
‡2
NUKAT|n 2015183984
|
996
|
|
|
‡2
LC|n 78041880
|
996
|
|
|
‡2
CYT|AC000454499
|
996
|
|
|
‡2
LNB|LNC10-000202245
|
996
|
|
|
‡2
DNB|102379425X
|
996
|
|
|
‡2
J9U|987007431582205171
|
996
|
|
|
‡2
LC|n 2003002518
|
996
|
|
|
‡2
ISNI|0000000052187656
|
996
|
|
|
‡2
ISNI|0000000107997163
|
996
|
|
|
‡2
PLWABN|9810560077905606
|
996
|
|
|
‡2
SUDOC|193884305
|
996
|
|
|
‡2
ISNI|0000000381957383
|
996
|
|
|
‡2
LC|n 84132772
|
996
|
|
|
‡2
KRNLK|KAC200709106
|
996
|
|
|
‡2
LC|no2006036555
|
996
|
|
|
‡2
ISNI|000000006427751X
|
996
|
|
|
‡2
LC|no 98066212
|
996
|
|
|
‡2
CYT|AC000660749
|
996
|
|
|
‡2
BNF|15045297
|
996
|
|
|
‡2
ISNI|0000000063447580
|
996
|
|
|
‡2
LC|n 2007047655
|
996
|
|
|
‡2
PLWABN|9812807240505606
|
996
|
|
|
‡2
LC|nr 96020721
|
996
|
|
|
‡2
LC|no2023068189
|
996
|
|
|
‡2
LC|nr 88001082
|
996
|
|
|
‡2
SUDOC|157288552
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|